Eli Lilly and (LLY)
826.57
4.06 (0.49%)
At close: Mar 31, 2025, 3:59 PM
824.48
-0.25%
Pre-market: Apr 01, 2025, 04:18 AM EDT
Immunology Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 1.19B | 351.7M | +42.17% |
| Mar 31, 2024 | 834M | -152.9M | -15.49% |
| Sep 30, 2023 | 986.9M | 58.4M | +6.29% |
| Jun 30, 2023 | 928.5M | 150.7M | +19.38% |
| Mar 31, 2023 | 777.8M | -88.6M | -10.23% |
| Sep 30, 2022 | 866.4M | 69.9M | +8.78% |
| Jun 30, 2022 | 796.5M | 48.4M | +6.47% |
| Mar 31, 2022 | 748.1M | -256.8M | -25.55% |
| Sep 30, 2021 | 1B | 219.5M | +27.95% |
| Jun 30, 2021 | 785.4M | 171.5M | +27.94% |
| Mar 31, 2021 | 613.9M | -13.2M | -2.10% |
| Sep 30, 2020 | 627.1M | 78.8M | +14.37% |
| Jun 30, 2020 | 548.3M | -37.5M | -6.40% |
| Mar 31, 2020 | 585.8M | 131.2M | +28.86% |
| Sep 30, 2019 | 454.6M | -1.5M | -0.33% |
| Jun 30, 2019 | 456.1M | 121.4M | +36.27% |
| Mar 31, 2019 | 334.7M | -559.8M | -62.58% |
| Mar 31, 2016 | 894.5M | -72.4M | -7.49% |
| Dec 31, 2015 | 966.9M | 105.6M | +12.26% |
| Sep 30, 2015 | 861.3M | -61.3M | -6.64% |
| Jun 30, 2015 | 922.6M | 163.6M | +21.55% |
| Mar 31, 2015 | 759M | -128.9M | -14.52% |
| Dec 31, 2014 | 887.9M | 18M | +2.07% |
| Sep 30, 2014 | 869.9M | -23.8M | -2.66% |
| Jun 30, 2014 | 893.7M | -70.7M | -7.33% |
| Mar 31, 2014 | 964.4M | -520.4M | -35.05% |
| Dec 31, 2013 | 1.48B | -393.3M | -20.94% |
| Sep 30, 2013 | 1.88B | -126.4M | -6.31% |
| Jun 30, 2013 | 2B | 155.7M | +8.42% |
| Mar 31, 2013 | 1.85B | -182.3M | -8.98% |
| Dec 31, 2012 | 2.03B | 215.3M | +11.86% |
| Sep 30, 2012 | 1.82B | -8.7M | -0.48% |
| Jun 30, 2012 | 1.82B | -79.2M | -4.16% |
| Mar 31, 2012 | 1.9B | -750.1M | -28.27% |
| Jun 30, 2011 | 2.65B | 2.6B | +4851.12% |
| Mar 31, 2011 | 53.6M | n/a | n/a |